Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+1.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+1.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$2.04M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$1.93M+328.0%
2019$450000.00+110.3%
2018$214000.00+89.4%
2017$113000.00-